Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications

被引:1
|
作者
Alatawi, Hind M. [1 ]
Alhwiti, Shemah S. [1 ]
Alsharif, Khwlah A. [1 ]
Albalawi, Shyma S. [1 ]
Abusaleh, Shroug M. [1 ]
Sror, Ghada K. [1 ]
Qushawy, Mona [2 ,3 ]
机构
[1] Univ Tabuk, Fac Pharm, Pharm D Program, Tabuk, Saudi Arabia
[2] Univ Tabuk, Fac Pharm, Dept Pharmaceut, Tabuk 71491, Saudi Arabia
[3] Sinai Univ, Fac Pharm, Dept Pharmaceut, Alarish 45511, North Sinai, Egypt
关键词
Nanostructured lipid carriers (NLCs); bioavailability; drug targeting; homogenization; chemotherapy; gene delivery; drug delivery systems; NANOPARTICLES SLN; ORAL BIOAVAILABILITY; DESIGN; FORMULATION; CLOTRIMAZOLE; COMBINATION; STABILITY;
D O I
10.2174/1872210517666230120142439
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
One of the drug delivery technologies is nanostructured lipid carriers (NLCs), which improve drug permeability and thus bioavailability. NLCs are nanoparticles made from a lipid matrix made up of a mixture of solid and liquid lipids. The inclusion of liquid lipids is useful in lowering the ordered structure of solid lipids, increasing nanoparticle loading capacity, and drug entrapment efficiency within NLCs. Hot homogenization, cold homogenization, micro-emulsion, emulsification-solvent diffusion, high shear homogenization, and/or ultrasonication techniques, double emulsion technique, melting dispersion method, membrane contractor technique, and evaporation solvent injection are some of the methods that can be used to make NLCs. Both hydrophilic and lipophilic medicines can be carried out by NLCs. They can deliver medications in a variety of ways, including oral, topical, transdermal, parenteral, and ophthalmic. During the process of preparing this review article, several distinct studies and patent reports about various methods of NLCs formulations, their various therapeutic applications, and various routes of administration were investigated and discussed. The study conducts an in-depth evaluation of the most recent research publications and patents. NLCs have been utilized to treat a variety of disorders, including cancer, fungal infections, bacterial infections, inflammation, liver diseases, and ocular infections, due to their benefits. They can deliver medications to specific locations throughout the body, allowing for drug targeting and a reduction in unwanted side effects. They can also be used to improve bioavailability, reduce the medication's supplied dose, and improve the drug's pharmacological activity.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 50 条
  • [31] Nanostructured lipid carriers for targeting drug delivery to the epidermal layer
    Gelfuso, Guilherme M.
    Cunha-Filho, Marcilio S. S.
    Gratieri, Tais
    [J]. THERAPEUTIC DELIVERY, 2016, 7 (11) : 735 - 737
  • [32] NANOSTRUCTURED LIPID CARRIERS: A NOVEL TARGETED DRUG DELIVERY SYSTEM
    Patil, Deepak
    Pattewar, Seema
    Palival, Sarvesh
    Patil, Gargi
    Sharma, Swapnil
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (10): : 4784 - 4793
  • [33] Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug
    Akhayacatra Chinsriwongkul
    Ponwanit Chareanputtakhun
    Tanasait Ngawhirunpat
    Theerasak Rojanarata
    Warisada Sila-on
    Uracha Ruktanonchai
    Praneet Opanasopit
    [J]. AAPS PharmSciTech, 2012, 13 : 150 - 158
  • [34] Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug
    Chinsriwongkul, Akhayacatra
    Chareanputtakhun, Ponwanit
    Ngawhirunpat, Tanasait
    Rojanarata, Theerasak
    Sila-on, Warisada
    Ruktanonchai, Uracha
    Opanasopit, Praneet
    [J]. AAPS PHARMSCITECH, 2012, 13 (01): : 150 - 158
  • [35] Nanostructured lipid carriers system: Recent advances in drug delivery
    Iqbal, Md Asif
    Md, Shadab
    Sahni, Jasjeet Kaur
    Baboota, Sanjula
    Dang, Shweta
    Ali, Javed
    [J]. JOURNAL OF DRUG TARGETING, 2012, 20 (10) : 813 - 830
  • [36] Nanostructured lipid carriers for site-specific drug delivery
    Khosa, Archana
    Reddi, Satish
    Saha, Ranendra N.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 598 - 613
  • [37] Nanostructured lipid carriers as vehicles for transdermal iontophoretic drug delivery
    Liu, W.
    Yang, X. L.
    Zhu, Y. L.
    Chen, H. B.
    Xu, H. B.
    [J]. 2005 27TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2005, : 1236 - 1239
  • [38] Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
    Chauhan, Iti
    Yasir, Mohd
    Verma, Madhu
    Singh, Alok Pratap
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2020, 10 (02) : 150 - 165
  • [39] Nanostructured lipid carriers and their current application in targeted drug delivery
    Jaiswal, Piyush
    Gidwani, Bina
    Vyas, Amber
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (01) : 27 - 40
  • [40] SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
    Ali Sabouri Shirazi
    Reyhaneh Varshochian
    Mahsa Rezaei
    Yalda Hosseinzadeh Ardakani
    Rassoul Dinarvand
    [J]. Journal of Materials Science: Materials in Medicine, 2021, 32